Rapamycin modulated brain-derived neurotrophic factor and B-cell lymphoma 2 to mitigate autism spectrum disorder in rats.
about
Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.Clustering the autisms using glutamate synapse protein interaction networks from cortical and hippocampal tissue of seven mouse models
P2860
Rapamycin modulated brain-derived neurotrophic factor and B-cell lymphoma 2 to mitigate autism spectrum disorder in rats.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rapamycin modulated brain-deri ...... ism spectrum disorder in rats.
@en
Rapamycin modulated brain-deri ...... ism spectrum disorder in rats.
@nl
type
label
Rapamycin modulated brain-deri ...... ism spectrum disorder in rats.
@en
Rapamycin modulated brain-deri ...... ism spectrum disorder in rats.
@nl
prefLabel
Rapamycin modulated brain-deri ...... ism spectrum disorder in rats.
@en
Rapamycin modulated brain-deri ...... ism spectrum disorder in rats.
@nl
P2093
P2860
P356
P1476
Rapamycin modulated brain-deri ...... ism spectrum disorder in rats.
@en
P2093
Jin-Feng Ni
Li-Ming Liu
P2860
P304
P356
10.2147/NDT.S125088
P407
P577
2017-03-20T00:00:00Z